| 期刊全稱 | Biotargets of Cancer in Current Clinical Practice | | 影響因子2023 | Mauro Bologna | | 視頻video | http://file.papertrans.cn/189/188637/188637.mp4 | | 發(fā)行地址 | Provides the latest information on the validation status of each novel biomarker.Covers the present debate on potential clinical use of newly discovered biochemical markers and on patentability of gen | | 學科分類 | Current Clinical Pathology | | 圖書封面 |  | | 影響因子 | .Biotargets of Cancer in Current Clinical Practice. presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed. | | Pindex | Book 2012 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-8 14:05
發(fā)表于 2025-3-21 16:39:36
